Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 2/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22277717 | 0.92 | CYP2C9 (0.33) | CYP2C9MEN1KMT2AALDH1A1LMNA | |
| SCHEMBL22277658 | 0.90 | CYP2C9 (0.32) | CYP2C9 | |
| SCHEMBL22277325 | 0.90 | FFAR4 (0.33) | CYP2C9 | |
| SCHEMBL17154214 | 0.90 | HTR2A (0.30) | — | |
| SCHEMBL22277293 | 0.90 | HTR2A (0.30) | — | |
| SCHEMBL11953627 | 0.89 | — | — | |
| SCHEMBL22277707 | 0.88 | KDM1A (0.32) | KDM1ACYP2C9MEN1KMT2AALDH1A1 | |
| SCHEMBL22277675 | 0.87 | KDM1A (0.34) | KDM1ACYP2C9MEN1KMT2AALDH1A1 | |
| SCHEMBL14362936 | 0.87 | — | — | |
| SCHEMBL22277685 | 0.87 | CYP2C9 (0.44) | KDM1ACYP2C9MEN1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200239775-A1 | TETRACYCLIC LIQUID CRYSTAL COMPOUND HAVING DIATOMIC BONDING GROUP AND 2,3-DIFLUOROPHENYLENE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC CORPORATION (JP) | 2020-07-30 | — | — | US | disclosed |